BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

423 related articles for article (PubMed ID: 19809879)

  • 21. Polycystic ovarian syndrome.
    Khan KA; Stas S; Kurukulasuriya LR
    J Cardiometab Syndr; 2006; 1(2):125-30; quiz 131-2. PubMed ID: 17679815
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Children's Hospital Association consensus statements for comorbidities of childhood obesity.
    Estrada E; Eneli I; Hampl S; Mietus-Snyder M; Mirza N; Rhodes E; Sweeney B; Tinajero-Deck L; Woolford SJ; Pont SJ;
    Child Obes; 2014 Aug; 10(4):304-17. PubMed ID: 25019404
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Abdominal obesity: metabolic complications and consequences for the liver].
    Oldenburg B; Pijl H
    Ned Tijdschr Geneeskd; 2001 Jul; 145(27):1290-4. PubMed ID: 11475019
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Insulin resistance in children].
    Stąpor N; Beń-Skowronek I
    Pediatr Endocrinol Diabetes Metab; 2015; 20(3):107-15. PubMed ID: 26615047
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metabolic inflexibility in women with polycystic ovary syndrome: a systematic review.
    Rimmer M; Tan BK; Teede H; Thangaratinam S; H Al Wattar B
    Gynecol Endocrinol; 2020 Jun; 36(6):501-507. PubMed ID: 31793357
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Childhood obesity and insulin resistance.
    Maclaren NK; Gujral S; Ten S; Motagheti R
    Cell Biochem Biophys; 2007; 48(2-3):73-8. PubMed ID: 17709876
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence of nonalcoholic fatty liver disease increased with type 2 diabetes mellitus in overweight/obese youth with polycystic ovary syndrome.
    Patel-Sanchez N; Perito E; Tsai P; Raymond-Flesch M; Lodish M; Sarkar M
    J Pediatr Endocrinol Metab; 2023 May; 36(5):441-446. PubMed ID: 37060356
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardiometabolic risk in obese children.
    Chung ST; Onuzuruike AU; Magge SN
    Ann N Y Acad Sci; 2018 Jan; 1411(1):166-183. PubMed ID: 29377201
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ovarian function and obesity--interrelationship, impact on women's reproductive lifespan and treatment options.
    Rachoń D; Teede H
    Mol Cell Endocrinol; 2010 Mar; 316(2):172-9. PubMed ID: 19818376
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular mechanisms of insulin resistance and associated diseases.
    Mlinar B; Marc J; Janez A; Pfeifer M
    Clin Chim Acta; 2007 Jan; 375(1-2):20-35. PubMed ID: 16956601
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Advanced glycation end products and their relevance in female reproduction.
    Merhi Z
    Hum Reprod; 2014 Jan; 29(1):135-45. PubMed ID: 24173721
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Childhood Obesity: Causes, Consequences, and Management.
    Gurnani M; Birken C; Hamilton J
    Pediatr Clin North Am; 2015 Aug; 62(4):821-40. PubMed ID: 26210619
    [TBL] [Abstract][Full Text] [Related]  

  • 33. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME - PART 2.
    Goodman NF; Cobin RH; Futterweit W; Glueck JS; Legro RS; Carmina E; ; ;
    Endocr Pract; 2015 Dec; 21(12):1415-26. PubMed ID: 26642102
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Insulin resistance: the clinical spectrum.
    Mantzoros CS; Flier JS
    Adv Endocrinol Metab; 1995; 6():193-232. PubMed ID: 7671097
    [No Abstract]   [Full Text] [Related]  

  • 35. What are the risk factors and settings for non-alcoholic fatty liver disease in Asia-Pacific?
    Fan JG; Saibara T; Chitturi S; Kim BI; Sung JJ; Chutaputti A;
    J Gastroenterol Hepatol; 2007 Jun; 22(6):794-800. PubMed ID: 17498218
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Associations of vitamin D with insulin resistance, obesity, type 2 diabetes, and metabolic syndrome.
    Wimalawansa SJ
    J Steroid Biochem Mol Biol; 2018 Jan; 175():177-189. PubMed ID: 27662816
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of obesity and adiposity in polycystic ovary syndrome.
    Diamanti-Kandarakis E
    Int J Obes (Lond); 2007 Nov; 31 Suppl 2():S8-13; discussion S31-2. PubMed ID: 17968437
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Polycystic ovary syndrome and insulin: our understanding in the past, present and future.
    Mayer SB; Evans WS; Nestler JE
    Womens Health (Lond); 2015 Mar; 11(2):137-49. PubMed ID: 25776288
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metabolic effects of obesity on reproduction.
    Pasquali R; Gambineri A
    Reprod Biomed Online; 2006 May; 12(5):542-51. PubMed ID: 16790096
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metabolic syndrome: identifying the risk factors.
    Lottenberg SA; Glezer A; Turatti LA
    J Pediatr (Rio J); 2007 Nov; 83(5 Suppl):S204-8. PubMed ID: 18038021
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.